$0.601
-0.0697[-10.39%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$0.6377
0.0367[6.11%]
| Open0.600 | Close0.601 |
| Vol / Avg.417.991K / 244.183K | Mkt Cap9.820M |
| Day Range0.560 - 0.670 | 52 Wk Range0.550 - 4.800 |
AcelRx Pharmaceuticals Stock (NASDAQ:ACRX), Key Statistics
AcelRx Pharmaceuticals Stock (NASDAQ: ACRX) analysis, key statistics.
Valuation Measures
Enterprise Value
652.3K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3.05
Price / Book (mrq)
1.05
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-492.02%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
0.1
Total Liabilities (Quarterly)
7.3M
Total Assets
17.7M
Total Liabilities
7.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-1727.67%
EBIT Margin
-1568.77%
EBITDA Margin
-1549.41%
Operating Margin
-1568.77%
AcelRx Pharmaceuticals Stock (NASDAQ:ACRX), Key Statistics
AcelRx Pharmaceuticals Stock (NASDAQ: ACRX) analysis, key statistics.
Valuation Measures
Enterprise Value
652.3K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3.05
Price / Book (mrq)
1.05
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-492.02%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
0.1
Total Liabilities (Quarterly)
7.3M
Total Assets
17.7M
Total Liabilities
7.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-1727.67%
EBIT Margin
-1568.77%
EBITDA Margin
-1549.41%
Operating Margin
-1568.77%
AcelRx Pharmaceuticals Stock (NASDAQ:ACRX), Key Statistics
AcelRx Pharmaceuticals Stock (NASDAQ: ACRX) analysis, key statistics.
Valuation Measures
Enterprise Value
652.3K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3.05
Price / Book (mrq)
1.05
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-492.02%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
0.1
Total Liabilities (Quarterly)
7.3M
Total Assets
17.7M
Total Liabilities
7.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-1727.67%
EBIT Margin
-1568.77%
EBITDA Margin
-1549.41%
Operating Margin
-1568.77%
AcelRx Pharmaceuticals Stock (NASDAQ:ACRX), Key Statistics
AcelRx Pharmaceuticals Stock (NASDAQ: ACRX) analysis, key statistics.
Valuation Measures
Enterprise Value
652.3K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3.05
Price / Book (mrq)
1.05
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-492.02%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
0.1
Total Liabilities (Quarterly)
7.3M
Total Assets
17.7M
Total Liabilities
7.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-1727.67%
EBIT Margin
-1568.77%
EBITDA Margin
-1549.41%
Operating Margin
-1568.77%
AcelRx Pharmaceuticals Stock (NASDAQ:ACRX), Key Statistics
AcelRx Pharmaceuticals Stock (NASDAQ: ACRX) analysis, key statistics.
Valuation Measures
Enterprise Value
652.3K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3.05
Price / Book (mrq)
1.05
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-492.02%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
0.1
Total Liabilities (Quarterly)
7.3M
Total Assets
17.7M
Total Liabilities
7.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-1727.67%
EBIT Margin
-1568.77%
EBITDA Margin
-1549.41%
Operating Margin
-1568.77%
AcelRx Pharmaceuticals Stock (NASDAQ:ACRX), Key Statistics
AcelRx Pharmaceuticals Stock (NASDAQ: ACRX) analysis, key statistics.
Valuation Measures
Enterprise Value
652.3K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3.05
Price / Book (mrq)
1.05
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-492.02%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
0.1
Total Liabilities (Quarterly)
7.3M
Total Assets
17.7M
Total Liabilities
7.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-1727.67%
EBIT Margin
-1568.77%
EBITDA Margin
-1549.41%
Operating Margin
-1568.77%
AcelRx Pharmaceuticals Stock (NASDAQ:ACRX), Key Statistics
AcelRx Pharmaceuticals Stock (NASDAQ: ACRX) analysis, key statistics.
Valuation Measures
Enterprise Value
652.3K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3.05
Price / Book (mrq)
1.05
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-492.02%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
0.1
Total Liabilities (Quarterly)
7.3M
Total Assets
17.7M
Total Liabilities
7.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-1727.67%
EBIT Margin
-1568.77%
EBITDA Margin
-1549.41%
Operating Margin
-1568.77%
AcelRx Pharmaceuticals Stock (NASDAQ:ACRX), Key Statistics
AcelRx Pharmaceuticals Stock (NASDAQ: ACRX) analysis, key statistics.
Valuation Measures
Enterprise Value
652.3K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3.05
Price / Book (mrq)
1.05
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-492.02%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
0.1
Total Liabilities (Quarterly)
7.3M
Total Assets
17.7M
Total Liabilities
7.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-1727.67%
EBIT Margin
-1568.77%
EBITDA Margin
-1549.41%
Operating Margin
-1568.77%
AcelRx Pharmaceuticals Stock (NASDAQ:ACRX), Key Statistics
AcelRx Pharmaceuticals Stock (NASDAQ: ACRX) analysis, key statistics.
Valuation Measures
Enterprise Value
652.3K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3.05
Price / Book (mrq)
1.05
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-492.02%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
0.1
Total Liabilities (Quarterly)
7.3M
Total Assets
17.7M
Total Liabilities
7.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-1727.67%
EBIT Margin
-1568.77%
EBITDA Margin
-1549.41%
Operating Margin
-1568.77%